137 related articles for article (PubMed ID: 14766749)
1. Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors.
Brown K; Long JM; Vial SC; Dedi N; Dunster NJ; Renwick SB; Tanner AJ; Frantz JD; Fleming MA; Cheetham GM
J Biol Chem; 2004 Apr; 279(18):18727-32. PubMed ID: 14766749
[TBL] [Abstract][Full Text] [Related]
2. The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors.
Jin L; Pluskey S; Petrella EC; Cantin SM; Gorga JC; Rynkiewicz MJ; Pandey P; Strickler JE; Babine RE; Weaver DT; Seidl KJ
J Biol Chem; 2004 Oct; 279(41):42818-25. PubMed ID: 15292186
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
[TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Zhong Y; Dong S; Strattan E; Ren L; Butchar JP; Thornton K; Mishra A; Porcu P; Bradshaw JM; Bisconte A; Owens TD; Verner E; Brameld KA; Funk JO; Hill RJ; Johnson AJ; Dubovsky JA
J Biol Chem; 2015 Mar; 290(10):5960-78. PubMed ID: 25593320
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
Hawkins J; Marcy A
Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper.
Wang Z; Liu J; Sudom A; Ayres M; Li S; Wesche H; Powers JP; Walker NP
Structure; 2006 Dec; 14(12):1835-44. PubMed ID: 17161373
[TBL] [Abstract][Full Text] [Related]
7. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine.
Lamers MB; Antson AA; Hubbard RE; Scott RK; Williams DH
J Mol Biol; 1999 Jan; 285(2):713-25. PubMed ID: 9878439
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog.
Boggon TJ; Li Y; Manley PW; Eck MJ
Blood; 2005 Aug; 106(3):996-1002. PubMed ID: 15831699
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket.
Harling JD; Deakin AM; Campos S; Grimley R; Chaudry L; Nye C; Polyakova O; Bessant CM; Barton N; Somers D; Barrett J; Graves RH; Hanns L; Kerr WJ; Solari R
J Biol Chem; 2013 Sep; 288(39):28195-206. PubMed ID: 23935099
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).
MacKinnon CH; Lau K; Burch JD; Chen Y; Dines J; Ding X; Eigenbrot C; Heifetz A; Jaochico A; Johnson A; Kraemer J; Kruger S; Krülle TM; Liimatta M; Ly J; Maghames R; Montalbetti CA; Ortwine DF; Pérez-Fuertes Y; Shia S; Stein DB; Trani G; Vaidya DG; Wang X; Bromidge SM; Wu LC; Pei Z
Bioorg Med Chem Lett; 2013 Dec; 23(23):6331-5. PubMed ID: 24138940
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H
Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK).
Wang X; Xue G; Pan Z
Eur J Med Chem; 2020 Feb; 187():111918. PubMed ID: 31830635
[TBL] [Abstract][Full Text] [Related]
14. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.
Atwell S; Adams JM; Badger J; Buchanan MD; Feil IK; Froning KJ; Gao X; Hendle J; Keegan K; Leon BC; Müller-Dieckmann HJ; Nienaber VL; Noland BW; Post K; Rajashankar KR; Ramos A; Russell M; Burley SK; Buchanan SG
J Biol Chem; 2004 Dec; 279(53):55827-32. PubMed ID: 15507431
[TBL] [Abstract][Full Text] [Related]
15. Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.
Moriarty KJ; Winters M; Qiao L; Ryan D; DesJarlis R; Robinson D; Cook BN; Kashem MA; Kaplita PV; Liu LH; Farrell TM; Khine HH; King J; Pullen SS; Roth GP; Magolda R; Takahashi H
Bioorg Med Chem Lett; 2008 Oct; 18(20):5537-40. PubMed ID: 18819794
[TBL] [Abstract][Full Text] [Related]
16. An Autoinhibitory Role for the Pleckstrin Homology Domain of Interleukin-2-Inducible Tyrosine Kinase and Its Interplay with Canonical Phospholipid Recognition.
Devkota S; Joseph RE; Boyken SE; Fulton DB; Andreotti AH
Biochemistry; 2017 Jun; 56(23):2938-2949. PubMed ID: 28516764
[TBL] [Abstract][Full Text] [Related]
17. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor.
Lucet IS; Fantino E; Styles M; Bamert R; Patel O; Broughton SE; Walter M; Burns CJ; Treutlein H; Wilks AF; Rossjohn J
Blood; 2006 Jan; 107(1):176-83. PubMed ID: 16174768
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).
Trani G; Barker JJ; Bromidge SM; Brookfield FA; Burch JD; Chen Y; Eigenbrot C; Heifetz A; Ismaili MHA; Johnson A; Krülle TM; MacKinnon CH; Maghames R; McEwan PA; Montalbetti CAGN; Ortwine DF; Pérez-Fuertes Y; Vaidya DG; Wang X; Zarrin AA; Pei Z
Bioorg Med Chem Lett; 2014 Dec; 24(24):5818-5823. PubMed ID: 25455497
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.
Brazin KN; Mallis RJ; Fulton DB; Andreotti AH
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1899-904. PubMed ID: 11830645
[TBL] [Abstract][Full Text] [Related]
20. Regulatory intramolecular association in a tyrosine kinase of the Tec family.
Andreotti AH; Bunnell SC; Feng S; Berg LJ; Schreiber SL
Nature; 1997 Jan; 385(6611):93-7. PubMed ID: 8985255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
